Nutrition
Volume 26, Issue 4 , Pages 367-374 , April 2010

Improvement of constipation and liver function by plant-derived lactic acid bacteria: A double-blind, randomized trial

  • Fumiko Higashikawa, Ph.D.

      Affiliations

    • Department of Molecular Nutrition Sciences, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
    • Corresponding Author InformationCorresponding author: Tel.: +81-82-257-1533; fax: +81-82-257-1533.
    • ,
  • Masafumi Noda, Ph.D.

      Affiliations

    • Department of Molecular Nutrition Sciences, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
    • ,
  • Tomokazu Awaya, M.D., Ph.D.

      Affiliations

    • Clinical Research Center, Hiroshima University, Hiroshima, Japan
    • ,
  • Kazuhiro Nomura, B.S.

      Affiliations

    • Nomura Dairy Products Co., Ltd., Hiroshima, Japan
    • ,
  • Hirotaka Oku, B.S.

      Affiliations

    • Nomura Dairy Products Co., Ltd., Hiroshima, Japan
    • ,
  • Masanori Sugiyama, Ph.D.

      Affiliations

    • Department of Molecular Microbiology and Biotechnology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan

Received 20 January 2009 ,Accepted 17 May 2009.

References 

  1. Adolfsson O, Meydani SN, Russell RM. Yoghurt and gut function. Am J Clin Nutr. 2004;80:245–256
  2. Parvez S, Malik KA, Ah Kang S, Kim HY. Probiotics and their fermented food products are beneficial for health. J Appl Microbiol. 2006;100:1171–1185
  3. Giralt J, Regadera JP, Verges R, Romero J, de la Fuente I, Biete A, et al. Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial. Int J Radiat Oncol Biol Phys. 2008;71:1213–1219
  4. Marteau P, Cuillerier E, Meance S, Gerhardt MF, Myara A, Bouvier M, et al. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment Pharmacol Ther. 2002;16:587–593
  5. Wang KY, Li SN, Liu CS, Perng DS, Su YC, Wu DC, et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yoghurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr. 2004;80:737–741
  6. Savaiano DA, AbouElAnouar A, Smith DE, Levitt MD. Lactose malabsorption from yoghurt, pasteurized yoghurt, sweet acidophilus milk, and cultured milk in lactase-deficient individuals. Am J Clin Nutr. 1984;40:1219–1223
  7. Peters RK, Pike MC, Garabrant D, Mack TM. Diet and colon cancer in Los Angeles County, California. Cancer Causes Control. 1992;3:457–473
  8. Dennison C, Prasad M, Lloyd A, Bhattacharyya SK, Dhawan R, Coyne K. The health-related quality of life and economic burden of constipation. Pharmacoeconomics. 2005;23:461–476
  9. Irvine EJ, Ferrazzi S, Pare P, Thompson WG, Rance L. Health-related quality of life in functional GI disorders: focus on constipation and resource utilization. Am J Gastroenterol. 2002;97:1986–1993
  10. Peppas G, Alexiou VG, Mourtzoukou E, Falagas ME. Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol. 2008;8:5
  11. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003;361:512–519
  12. Picard C, Fioramonti J, Francois A, Robinson T, Neant F, Matuchansky C. Review article: bifidobacteria as probiotic agents—physiological effects and clinical benefits. Aliment Pharmacol Ther. 2005;22:495–512
  13. Fetissov SO, Hamze Sinno M, Coëffier M, Bole-Feysot C, Ducrotté P, Hökfelt T, et al. Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative modulation by gut microflora. Nutrition. 2008;24:348–359
  14. Naruszewicz M, Johansson ML, Zapolska-Downar D, Bukowska H. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr. 2002;76:1249–1255
  15. Xiao JZ, Kondo S, Takahashi N, Miyaji K, Oshida K, Hiramatsu A, et al. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci. 2003;86:2452–2461
  16. Kiessling G, Schneider J, Jahreis G. Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur J Clin Nutr. 2002;56:843–849
  17. Anderson JW, Gilliland SE. Effect of fermented milk (yoghurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J Am Coll Nutr. 1999;18:43–50
  18. Bukowska H, Pieczul-Mróz J, Jastrzebska M, Chełstowski K, Naruszewicz M. Decrease in fibrinogen and LDL-cholesterol upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol. Atherosclerosis. 1998;137:437–438
  19. Greany KA, Bonorden MJ, Hamilton-Reeves JM, McMullen MH, Wangen KE, Phipps WR, et al. Probiotic capsules do not lower plasma lipids in young women and men. Eur J Clin Nutr. 2008;62:232–237
  20. Simons LA, Amansec SG, Conway P. Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol. Nutr Metab Cardiovasc Dis. 2006;16:531–535
  21. Lewis SJ, Burmeister S. A double-blind placebo-controlled study of the effects of Lactobacillus acidophilus on plasma lipids. Eur J Clin Nutr. 2005;59:776–780
  22. Fuller R. Probiotics in man and animals. J Appl Bacteriol. 1989;66:365–378
  23. Dunne C, O'Mahony L, Murphy L, Thornton G, Morrissey D, O'Halloran S, et al. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr. 2001;73:386S–392S
  24. Holzapfel WH, Haberer P, Geisen R, Björkroth J, Schillinger U. Taxonomy and important features of probiotic microorganisms in food and nutrition. Am J Clin Nutr. 2001;73:365S–373S
  25. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32:920–924
  26. Riegler G, Esposito I. Bristol scale stool form. A still valid help in medical practice and clinical research. Tech Coloproctol. 2001;5:163–164
  27. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–1419
  28. Preiss D, Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond). 2008;115:141–150
  29. Xing HC, Li LJ, Xu KJ, Shen T, Chen YB, Sheng JF, et al. Protective role of supplement with foreign Bifidobacterium and Lactobacillus in experimental hepatic ischemia–reperfusion injury. J Gastroenterol Hepatol. 2006;21:647–656
  30. Chen L, Pan DD, Zhou J, Jiang YZ. Protective effect of selenium-enriched Lactobacillus on CCl4-induced liver injury in mice and its possible mechanisms. World J Gastroenterol. 2005;11:5795–5800
  31. Osman N, Adawi D, Ahrné S, Jeppsson B, Molin G. Endotoxin- and D-galactosamine–induced liver injury improved by the administration of Lactobacillus, Bifidobacterium and blueberry. Dig Liver Dis. 2007;39:849–856
  32. Adawi D, Ahrné S, Molin G. Effects of different probiotic strains of Lactobacillus and Bifidobacterium on bacterial translocation and liver injury in an acute liver injury model. Int J Food Microbiol. 2001;70:213–220

 This work was jointly supported by part of the Next Generation Key Industrial Project granted by the Chugoku Bureau of Economy, Trade, and Industry, Japan, in fiscal year 2007, and Nomura Dairy Products Co., Ltd.

PII: S0899-9007(09)00229-9

doi: 10.1016/j.nut.2009.05.008

Nutrition
Volume 26, Issue 4 , Pages 367-374 , April 2010

Article Tools

* Image Usage & Resolution